Article Sidebar

PDF (Tiếng Việt)
Published: 2026-07-06
Abstract Views: 0
Views PDF (Tiếng Việt): 0
DOI: https://doi.org/10.52852/tcncyh.v203i6.5125
Issue
Vol. 203 No. 6 (2026)
Section
Các bài báo
How to Cite
Tốt, Đặng V., Du, V. V., Hưng, M. T., Trang, H. T., & Hằng, N. T. (2026). Pregnancy outcomes and factors associated with severe features among women with early-onset preeclampsia at Hanoi Obstetrics and Gynecology Hospital. Journal of Medical Research, 203(6), 280-288. https://doi.org/10.52852/tcncyh.v203i6.5125

Pregnancy outcomes and factors associated with severe features among women with early-onset preeclampsia at Hanoi Obstetrics and Gynecology Hospital

Dang Van Tot, Vu Van Du, Mai Trong Hung, Ho Thi Trang, Nguyen Thi Hang

Main Article Content

Abstract

This study aimed to describe pregnancy outcomes in women with early-onset preeclampsia and to analyze several factors associated with severe preeclampsia in this group of patients. A retrospective cross-sectional study was conducted on 216 patients with early-onset preeclampsia (< 34 weeks of gestation) treated at Hanoi Obstetrics and Gynecology Hospital from 2021 to 2025. The results showed that the mean maternal age was 32.5 ± 5.2 years old, and the mean gestational age at admission was 30.4 ± 2.6 weeks; fetal growth restriction was 37.0%. The cesarean section rate was high (94.4%), most cases delivered before 34 weeks gestation (81.9%), and the median birth weight was 1400 g. Multivariable logistic regression analysis showed that proteinuria ≥ 3 g/l was an independent factor associated with preeclampsia with severe features (aOR = 1.86; 95% CI: 1.04 – 3.31). Early-onset preeclampsia is associated with a high rate of preterm birth and maternal complications, and proteinuria may be a useful indicator of disease severity in clinical practice.

Article Details

Keywords

Early-onset preeclampsia, preeclampsia with severe features, proteinuria, uric acid

References

1. World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: World Health Organization; 2022.
2. American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin No. 222. Obstet Gynecol. 2020;135(6):e237-e260.
3. Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275-289.
4. Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999-1011.
5. Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148-169.
6. Rana S, et al. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019;124(7):1094-1112.
7. Thangaratinam S, Coomarasamy A, O’Mahony F, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMJ. 2009;339:b2451.
8. Morris RK, et al. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ. 2012;345:e4342.
9. Bellos I, Pergialiotis V, Loutradis D, Daskalakis G. The prognostic role of serum uric acid levels in preeclampsia: a meta-analysis. J Clin Hypertens (Greenwich). 2020;22(5):826-834.
10. Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2013;42(6):634-643.
11. Pinheiro RL, Areia AL, Mota Pinto A, Donato H. Advanced Maternal Age: Adverse Outcomes of Pregnancy, A Meta-Analysis. Acta Med Port. 2019;32(3):219-226.
12. Gordijn SJ, Beune IM, Thilaganathan B, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333-339.
13. Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36(2):86-98.
14. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-544.e12.
15. McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12(12):CD004454.
16. Wiles K, Chappell LC, Clark K, et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 2019;20(1):401.
17. Koopmans CM, et al. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):8-14.